LP
LSBPW

LMR Partners’s LakeShore Biopharma Warrants LSBPW Stock Holding History

LMR Partners’s Portfolio LSBPW Stock Details LSBPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,052,461
Closed -$42K – 1699
2025
Q2 		$42K Hold
1,052,461
– – ﹤0.01% 1227
2025
Q1 		$43.4K Hold
1,052,461
– – ﹤0.01% 1205
2024
Q4 		$83.6K Buy
+1,052,461
New +$54.1K ﹤0.01% 1011
2024
Q3 		– Sell
-1,052,461
Closed -$66.4K – 1566
2024
Q2 		$92.6K Hold
1,052,461
– – ﹤0.01% 896
2024
Q1 		$75.4K Hold
1,052,461
– – ﹤0.01% 947
2023
Q4 		$40K Hold
1,052,461
– – ﹤0.01% 805
2023
Q3 		$43.4K Hold
1,052,461
– – ﹤0.01% 735
2023
Q2 		$49.5K Hold
1,052,461
– – ﹤0.01% 667
2023
Q1 		$1.68M Buy
+1,052,461
New +$159K 0.03% 474

Other funds holding LSBPW

HIM
HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

LMR Partners's LSBPW Position: Q3 2025 in Review

LMR Partners sold out of LakeShore Biopharma Warrants (LSBPW) in Q3 2025, closing a stake of 1,052,461 shares — an estimated $42K sold.

LMR Partners first reported a position in LSBPW in Q1 2023 and held it in 9 quarters. The position peaked at $1.68M in Q1 2023. 3 funds tracked by Wall St. Rank hold LSBPW as of Q3 2025.

  • LMR Partners reported no remaining LakeShore Biopharma Warrants position as of Q3 2025 after selling out during the quarter.
  • LMR Partners sold 1,052,461 LakeShore Biopharma Warrants shares in Q3 2025, an estimated $42K.
  • LMR Partners first reported a position in LakeShore Biopharma Warrants in Q1 2023 and held it in 9 quarters.
  • LMR Partners's LakeShore Biopharma Warrants position peaked at $1.68M in Q1 2023.
  • 3 funds tracked by Wall St. Rank held LakeShore Biopharma Warrants as of Q3 2025.

Based on LMR Partners's 13F filing for Q3 2025, filed 14 Nov 2025.